Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Farmers Insurance
Chubb
Baxter
Merck
Moodys
Accenture
Cantor Fitzgerald

Generated: May 21, 2018

DrugPatentWatch Database Preview

AGRYLIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Agrylin, and when can generic versions of Agrylin launch?

Agrylin is a drug marketed by Shire Llc and is included in one NDA.

The generic ingredient in AGRYLIN is anagrelide hydrochloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the anagrelide hydrochloride profile page.
Drug patent expirations by year for AGRYLIN
Pharmacology for AGRYLIN
Synonyms for AGRYLIN
2216AH
4CA-0160
58579-51-4
6,7-Dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3H)-one monohydrochloride
6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one hydrochloride
6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride
6,7-dichloro-1H,2H,3H,5H-imidazolidino[2,1-b]quinazolin-2-one hydrochloride
6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one;hydrochloride
6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one hydrochloride
6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride
AC-1309
AC1L28KG
Agrelin
AK146267
AKOS015845752
AKOS015966621
AN-250
Anagrelid hydrochlorid
Anagrelide (hydrochloride)
Anagrelide HCL
ANAGRELIDE HYDROCHLORIDE
Anagrelide hydrochloride (USAN)
Anagrelide hydrochloride [USAN]
Anagrelide hydrochloride hydrate
Anagrelide Hydrocholoride
BC215602
BCP9000300
BL 4162A
BL-4162A
BL4162A
BMY 26538-01
BMY-26538-01
C10H7Cl2N3O.ClH
C10H7Cl2N3O.HCl
CCG-101018
CHEBI:55345
CHEMBL1200759
CPD000469168
CS-2743
CTK8F0343
D02933
HY-B0523A
Imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, monohydrochloride
Imidazo[2,6,7-dichloro-1,5-dihydro-, monochloride
KB-293061
KRN-654
KS-000010T1
LS-80465
MFCD01720337
MLS001401396
MLS006011205
MolPort-020-008-042
NC00268
NE30452
NSC-724577
NSC-759170
NSC724577
NSC759170
Pharmakon1600-01505590
s3172
SAM001246604
SC-94609
SCHEMBL18304651
SCHEMBL318593
SMR000469168
SMR004702973
SPD 422
SPD-422
ST24044982
TC-070921
Thromboreductin
TVWRQCIPWUCNMI-UHFFFAOYSA-N
UNII-VNS4435G39
VNS4435G39
Xagrid
Xagrid (TN)
Z2326989478

US Patents and Regulatory Information for AGRYLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Llc AGRYLIN anagrelide hydrochloride CAPSULE;ORAL 020333-001 Mar 14, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Shire Llc AGRYLIN anagrelide hydrochloride CAPSULE;ORAL 020333-002 Mar 14, 1997 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
UBS
Queensland Health
Chinese Patent Office
Colorcon
Covington
US Department of Justice
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.